Abstract
Background: Hepatocellular carcinoma (HCC) is the world’s second most deadly cancer, and metabolic reprogramming is its distinguishing feature. Among metabolite profiling, variation in amino acid metabolism supports tumor proliferation and metastasis to the most extent, yet a systematic study on the role of amino acid metabolism-related genes in HCC is still lacking. An effective amino acid metabolism-related prediction signature is urgently needed to assess the prognosis of HCC patients for individualized treatment.Materials and Methods: RNA-seq data of HCC from the TCGA-LIHC and GSE14520 (GPL3921) datasets were defined as the training set and validation set, respectively. Amino acid metabolic genes were extracted from the Molecular Signature Database. Univariate Cox and LASSO regression analyses were performed to build a predictive risk signature. K-M curves, ROC curves, and univariate and multivariate Cox regression were conducted to evaluate the predictive value of this risk signature. Functional enrichment was analyzed by GSEA and CIBERSORTx software.Results: A nine-gene amino acid metabolism-related risk signature including B3GAT3, B4GALT2, CYB5R3, GNPDA1, GOT2, HEXB, HMGCS2, PLOD2, and SEPHS1 was constructed to predict the overall survival (OS) of HCC patients. Patients were separated into high-risk and low-risk groups based on risk scores and low-risk patients had lower risk scores and longer survival time. Univariate and multivariate Cox regression verified that this signature was an independent risk factor for HCC. ROC curves showed that this risk signature can effectively predict the 1-, 2-, 3- and 5-year survival times of patients with HCC. Additionally, prognostic nomograms were established based on the training set and validation set. These genes were closely correlated with the immune regulation.Conclusion: Our study identified a nine-gene amino acid metabolism-related risk signature and built predictive nomograms for OS in HCC. These findings will help us to personalize the treatment of liver cancer patients.
Highlights
A series of biochemical changes during cancer development can promote infinite tumor cell proliferation, activate tissue invasion and metastasis, and prevent tumor cell growth from being inhibited
There were 393 amino acid metabolic genes in the training set, and 327 amino acid metabolism-related genes were obtained after intersecting with the validation set
No influence of two genes (CYB5R3 and hexosaminidase subunit beta (HEXB)) in cancers has been reported, but our study found that upregulation of CYB5R3 and HEXB was significantly linked to the poor prognosis of Hepatocellular carcinoma (HCC) patients
Summary
A series of biochemical changes during cancer development can promote infinite tumor cell proliferation, activate tissue invasion and metastasis, and prevent tumor cell growth from being inhibited. Amino acids associate with the metabolism of glucose, lipids and nucleotides, which are crucial for tumor proliferation, invasion and metastasis (Li and Zhang, 2016; Vettore et al, 2020). Many cancers require exogenous supplementation with glutamine to maintain tumor cell proliferation, in a process called “glutamine dependence”(Lukey et al, 2017). Glycine and threonine metabolism and the one-carbon unit product derived from these processes properly satisfy tumor cell proliferation and maintain the redox, genetic and epigenetic state (Locasale, 2013). Variation in amino acid metabolism supports tumor proliferation and metastasis to the most extent, yet a systematic study on the role of amino acid metabolism-related genes in HCC is still lacking. An effective amino acid metabolism-related prediction signature is urgently needed to assess the prognosis of HCC patients for individualized treatment
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
